share_log

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Treco Douglas A

CRISPR Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Treco Douglas A

CRISPR Therapeutics | 4：持股變動聲明-董事 Treco Douglas A
美股sec公告 ·  06/01 04:21
牛牛AI助理已提取核心訊息
Douglas A. Treco, associated with CRISPR Therapeutics AG [CRSP], was involved in a transaction on May 30, 2024. The specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. As this information is crucial for investors, further updates are anticipated to provide a clearer picture of the transaction's impact on CRISPR Therapeutics' stock.
Douglas A. Treco, associated with CRISPR Therapeutics AG [CRSP], was involved in a transaction on May 30, 2024. The specific details regarding the nature of the transaction, such as the action type, status, number of shares involved, transaction price, and the resulting number of shares held after the action, have not been disclosed. As this information is crucial for investors, further updates are anticipated to provide a clearer picture of the transaction's impact on CRISPR Therapeutics' stock.
與CRISPR Therapeutics AG [CRSP] 相關的道格拉斯·特雷科於2024年5月30日參與了一筆交易。有關交易性質的具體細節，例如行動類型、狀態、所涉股票數量、交易價格以及行動後由此產生的持股數量，尚未披露。由於這些信息對投資者至關重要，預計將進一步更新該交易對CRISPR Therapeutics股票的影響。
與CRISPR Therapeutics AG [CRSP] 相關的道格拉斯·特雷科於2024年5月30日參與了一筆交易。有關交易性質的具體細節，例如行動類型、狀態、所涉股票數量、交易價格以及行動後由此產生的持股數量，尚未披露。由於這些信息對投資者至關重要，預計將進一步更新該交易對CRISPR Therapeutics股票的影響。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。